QIAGEN N.V. Files Q1 2025 6-K Report

Ticker: QGEN · Form: 6-K · Filed: May 13, 2025 · CIK: 1015820

Qiagen N.V. 6-K Filing Summary
FieldDetail
CompanyQiagen N.V. (QGEN)
Form Type6-K
Filed DateMay 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: quarterly-report, foreign-private-issuer, sec-filing

Related Tickers: QGEN

TL;DR

QIAGEN dropped its Q1 2025 6-K, check it for performance updates.

AI Summary

QIAGEN N.V. filed a Form 6-K for the quarterly period ended March 31, 2025. The report is for a foreign private issuer and includes information on other matters, signatures, and an exhibit index. The company's principal executive office is located in Venlo, The Netherlands.

Why It Matters

This filing provides an update on QIAGEN's financial reporting for the first quarter of 2025, which is crucial for investors to assess the company's performance and make informed decisions.

Risk Assessment

Risk Level: low — This is a routine quarterly filing (6-K) and does not appear to contain any significant new risks or material adverse information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers that provides information which the registrant makes or is required to make public pursuant to the laws of the registrant's home country or jurisdiction, or which the registrant furnishes or is required to furnish to its security holders.

What period does this 6-K filing cover?

This 6-K filing covers the quarterly period ended March 31, 2025.

Where is QIAGEN N.V. headquartered?

QIAGEN N.V.'s principal executive office is located at Hulsterweg 82, 5912 PL Venlo, The Netherlands.

Is QIAGEN N.V. required to file annual reports on Form 20-F?

Yes, the filing indicates that QIAGEN N.V. files annual reports under cover of Form 20-F.

What are the main sections included in this 6-K filing?

The main sections included in this 6-K filing are 'Other Information', 'Signatures', and 'Exhibit Index'.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 13, 2025 regarding QIAGEN N.V. (QGEN).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing